Understand the biological logic behind REAC® therapy: why the body requires reorganization time and how it differs from traditional pharmacology.
The human body does not operate according to the binary logic of an “on/off” switch. As an extremely complex biological system, every process of change requires a progression that is consistent with the rhythms of physiology.
The fundamental difference between a pharmacological approach and one based on REAC® technology lies in the factor of time. While chemistry can force a rapid (and often temporary) response, REAC biomodulation respects biological timing.
The therapeutic pathway does not aim for an immediate but ephemeral reaction; it aims to trigger a stable reorganization of the nervous system and tissues. This requires the body to “re-learn” how to function in balance—a process that, by definition, is progressive.
Why are disorders such as chronic pain or neurovegetative anxiety so difficult to eradicate? The reason lies in the memory of biological circuits, which tend to maintain dysfunctional patterns even after the triggering cause has vanished.
An effective resolution requires:
The value of REAC protocols lies in the stability of the results. Since the improvement is not induced by an exogenous chemical effect but is the result of a real change in endogenous bioelectric communication, the benefits tend to persist over time, becoming the organism’s new functional standard.
Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.
She has dedicated her career to research and the development of innovative technologies for human well-being.
Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.
In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.
Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity
Learn more:
• Publications: PubMed – Rinaldi S, Fontani V
Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316
Profile and Mission
Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.
Research Milestones
Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:
Regenerative Medicine:
Anti-Senescence and Longevity:
Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:
Scientific Vision
Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.
Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V